Press release
Investigation ongoing for Investors in CDK Global, Inc. (NASDAQ: CDK) over potential Wrongdoing
An investigation on behalf of investors in CDK Global, Inc. (NASDAQ: CDK) shares over potential wrongdoing at CDK Global, Inc.
Investors who purchased shares of CDK Global, Inc. (NASDAQ: CDK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain CDK Global, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Hoffman Estates, IL based CDK Global, Inc., together with its subsidiaries, provides integrated data and technology solutions to the automotive, heavy truck, recreation, and heavy equipment industries in the United States and internationally. On April 7, 2022, CDK Global, Inc. (Nasdaq: CDK) has entered into an agreement to be acquired by Brookfield Business Partners, together with institutional partners (collectively "Brookfield"), for a total enterprise value of $8.3 billion. Under the terms of the merger agreement, Brookfield will commence a tender offer to acquire all of the outstanding shares of CDK. CDK shareholders will receive $54.87 per share in cash upon completion of the transaction.
However, At least one analyst has set the high target price for NASDAQ: CDK shares at $65.00 per share.
Those who are current investors in CDK Global, Inc. (NASDAQ: CDK) shares have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation ongoing for Investors in CDK Global, Inc. (NASDAQ: CDK) over potential Wrongdoing here
News-ID: 2668450 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for CDK
Cancer CDK Inhibitors Market 2021 | Detailed Report
According to Market Study Report, Cancer CDK Inhibitors Market provides a comprehensive analysis of the Cancer CDK Inhibitors Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Cancer CDK Inhibitors Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5087783
The report provides a…
CDK Websites See Significant Organic Traffic Increases
REUNION MARKETING
Data Beats Intuition
418 S. Dawson St.
Raleigh, North Carolina 27601
NEWS RELEASE
For Immediate Release
CDK Websites See Significant Organic Traffic Increases
The Recent Google Algorithm Affected Traffic Flows Across CMSs
August 20, 2018 — Reunion Marketing personnel noted a remarkable increase in organic traffic for CDK websites that directly coincides with a Google algorithm update.
While conducting regular audits, members of the Reunion team discovered a pattern of significant increases in organic website traffic throughout…
Dealer Management Market Excellent Growth | IBM, CA, Cox Automotive, CDK Global
The qualitative research study conducted by HTF MI titled “Global Dealer Management Market Size, Status and Forecast 2025” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global Dealer Managementmarket. The study provides forecasts for Dealer Management investments till 2022.
If you are involved in the Dealer Management industry or intend to be, then…
Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022 Report
“Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022” report highlights:
* Selectivity and Working Mechanism of a Cancer CDKs Inhibitor
* Recent Advances in the CDKs Related Cancer Therapy
* Global Cancer CDK Inhibitors Clinical Trials Insight: 45 Drugs in Pipeline
* Market Opportunity Assessment: More Than US$ 20 Billion (2022)
* Price Analysis of Cancer CDKs Inhibitors:
* Sales Analysis of Available Drugs: More Than US$ 2 Billion (2017)
Download Report Sample Weblink:…
Download Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022
“Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022” report gives comprehensive insight on clinical and non-clinical parameters related to emergence and growth of CDK inhibitors in cancer therapy. As per report findings, CDK inhibitors have emerged as new growth frontier for the organizations involved in the research, development, licensing and commercialization of targeted cancer therapies. There are 2 CDK inhibitors commercially available in the market for the treatment…
Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022
For Report Sample Contact: neeraj@kuickresearch.com
Report Weblink:https://www.kuickresearch.com/report-global-cancer-cdk-inhibitors-market-and-clinical-pipeline-outlook-2022.php
Table of Contents
1. Cyclin Dependent Kinase Inhibitors andndash;An Introduction to a Promising Cancer Therapeutic
1.1 History of Discoveries Leading to Cyclin Dependent Kinase Inhibitor Drug
1.2 An Insight into Cell Cycle, Cyclin and the Role of CDKs
1.3 Cyclin Dependent Kinase Inhibitors for Cancer - An Overview
2. Cyclin Dependent Kinase Pathway as Targets for Cancer Therapy
2.1…
